Alterity Therapeutics Ltd. (AU:ATH) has released an update.
Alterity Therapeutics Limited reports a change in substantial holding by The Bank of New York Mellon Corporation (BNYMC), with an increase in voting power from 38.52% to 39.55%. This shift occurred on May 1st, 2024, marking a notable change in the company’s shareholder structure. The update follows the previous notice provided a couple of weeks prior, reflecting the evolving interests of one of its significant investors.
For further insights into AU:ATH stock, check out TipRanks’ Stock Analysis page.
